Literature DB >> 12492498

The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.

Nancy Dumont1, Carlos L Arteaga.   

Abstract

Transforming growth factor beta (TGFbeta) members are secreted in biologically inactive complexes that must be activated in order to enable binding to their cell surface receptors. Interestingly, many of the proteins that can activate TGFbeta have been implicated in either suppressing or promoting tumorigenesis. Included among these are matrix proteins (thrombospondin-1), receptors (integrins alphanubeta6 and alphanubeta8) and proteases (matrix metalloproteases and plasmin). These proteins cannot only activate TGFbeta, but can also modulate cell responsiveness to TGFbeta. In this section, we review data highlighting the complexity and bidirectionality of TGFbeta matrix interactions within the tumor microenvironment, and propose that these dynamic interactions are a critical spatial and temporal determinant of the effects of TGFbeta on tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12492498     DOI: 10.1046/j.1432-0436.2002.700910.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

1.  Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yanli Guo; Zhifeng Chen; Zhibin Yang; Gang Kuang
Journal:  Mol Biol Rep       Date:  2011-07-22       Impact factor: 2.316

2.  PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

Authors:  Felicita Baratelli; Jay M Lee; Saswati Hazra; Ying Lin; Tonya C Walser; Dorthe Schaue; Peter S Pak; David Elashoff; Karen Reckamp; Ling Zhang; Michael C Fishbein; Sherven Sharma; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2010-06-30       Impact factor: 4.060

3.  In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.

Authors:  Cheong J Lee; Aaron C Spalding; Edgar Ben-Josef; Lidong Wang; Diane M Simeone
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

4.  Effects of transforming growth factor-beta in the development of inflammatory pseudotumour-like lesions in a murine model.

Authors:  Luciana Doria Guariniello; Mariangela Correa; Miriam Galvonas Jasiulionis; Joel Machado; José Antônio Silva; João Bosco Pesquero; Célia Regina Whitaker Carneiro
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

5.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

Review 6.  Using human genetics to improve safety assessment of therapeutics.

Authors:  Keren J Carss; Aimee M Deaton; Alberto Del Rio-Espinola; Dorothée Diogo; Mark Fielden; Diptee A Kulkarni; Jonathan Moggs; Peter Newham; Matthew R Nelson; Frank D Sistare; Lucas D Ward; Jing Yuan
Journal:  Nat Rev Drug Discov       Date:  2022-10-19       Impact factor: 112.288

7.  Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer.

Authors:  Maozhen Tian; William P Schiemann
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

Review 8.  Role of transforming growth factor beta in cancer microenvironment.

Authors:  Luis de la Cruz-Merino; Fernando Henao-Carrasco; Teresa García-Manrique; Pedro M Fernández-Salguero; Manuel Codes-Manuel de Villena
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

9.  Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.

Authors:  Italia Grenga; Renee N Donahue; Morgan L Gargulak; Lauren M Lepone; Mario Roselli; Marijo Bilusic; Jeffrey Schlom
Journal:  Urol Oncol       Date:  2017-11-02       Impact factor: 3.498

Review 10.  Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.

Authors:  James B McCarthy; Dorraya El-Ashry; Eva A Turley
Journal:  Front Cell Dev Biol       Date:  2018-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.